Multiple sclerosis: patients’ information sources and needs on disease symptoms and management
Albert I Matti1, Helen McCarl2, Pamela Klaer2, Miriam C Keane1, Celia S Chen1
1Department of Ophthalmology, Flinders Medical Centre and Flinders University, Bedford Park, SA, Australia; 2The Multiple Sclerosis Society of South Australia and Northern Territory, Klemzig, SA, Australia
Objective: To investigate the current information sources of patients with multiple sclerosis (MS) in the early stages of their disease and to identify patients’ preferred source of information. The relative amounts of information from the different sources were also compared.
Methods: Participants at a newly diagnosed information session organized by the Multiple Sclerosis Society of South Australia were invited to complete a questionnaire. Participants were asked to rate on a visual analog scale how much information they had received about MS and optic neuritis from different information sources and how much information they would like to receive from each of the sources.
Results: A close to ideal amount of information is being provided by the MS society and MS specialist nurses. There is a clear deficit between what information patients are currently receiving and the amount of information they actually want from various sources. Patients wish to receive significantly more information from treating general practitioners, eye specialists, neurologists, and education sessions. Patients have identified less than adequate information received on optic neuritis from all sources.
Conclusion: This study noted a clear information deficit regarding MS from all sources. This information deficit is more pronounced in relation to optic neuritis and needs to be addressed in the future.
Practice implications: More patient information and counselling needs to be provided to MS patients even at early stages of their disease, especially in relation to management of disease relapse.
Keywords: information sources, information needs, MS patients, optic neuritis
This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
Readers of this article also read:
A Patel, Andrew C Heinrich, Bobby Y Reddy, Pranela Rameshwar
Published Date: 4 February 2009
Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease
Stricker RB, DeLong AK, Green CL, Savely VR, Chamallas SN, Johnson L
Published Date: 6 September 2011
Chauhan A, Zubair S, Tufail S, Sherwani A, Sajid M, Raman SC, Azam A, Owais M
Published Date: 12 October 2011
Mansour AM, Shahin M, Kofoed PK, Parodi MB, Shami M, Schwartz SG
Published Date: 6 March 2012
Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo
Cai L, Wang X, Wang W, Qiu N, Wen J, Duan X, Li X, Chen X, Yang L, Qian Z, Wei Y, Chen L
Published Date: 14 August 2012
March ME, Sleiman PMA, Hakonarson H
Published Date: 17 April 2013
Quivy A, Daste A, Harbaoui A, Duc S, Bernhard JC, Gross-Goupil M, Ravaud A
Published Date: 19 April 2013
Glotzer OS, Fabian T, Chandra A, Bakhos CT
Published Date: 22 April 2013
Saksena R, Wong ST
Published Date: 17 May 2013
Ericson L, Ambring A, Björholt I, Dahm P
Published Date: 20 May 2013